Cialis Efficacy Reports from Real Users

What the Key Trials Actually Showed

Tadalafil's registration program enrolled over 4,000 men across multiple randomized, placebo-controlled studies. The numbers set the benchmark against which every forum post should be measured.

In the Brock et al. dose-response trial (N=1,112), men receiving tadalafil 20 mg reported successful intercourse in 81% of attempts, compared with 48% on placebo [1]. Mean International Index of Erectile Function (IIEF) erectile-function domain scores rose by approximately 7 points from baseline in the 20 mg group, a difference the authors classified as clinically meaningful. Across the full program, the 10 mg dose also outperformed placebo, though the 20 mg arm consistently produced higher completion rates [1].

A separate 12-week European trial by Porst et al. (N=348) confirmed the finding: 73% of intercourse attempts succeeded on 20 mg tadalafil versus 32% on placebo [2]. The European study also documented that efficacy persisted at 24 and 36 hours post-dose, a pharmacokinetic advantage driven by tadalafil's 17.5-hour elimination half-life [3]. No other PDE5 inhibitor in the class offers that window.

Dr. Harin Padma-Nathan, a urologist involved in multiple tadalafil trials, stated in a 2004 review: "The extended half-life of tadalafil fundamentally changes the patient experience by removing the need to time sexual activity around a narrow dosing window" [4]. That observation reappears, in less clinical language, across thousands of patient posts.

Forum and Review-Site Ratings: A Snapshot

Aggregated user reviews on Drugs.com give tadalafil an average rating of roughly 8.1 out of 10 based on over 300 submitted ratings for erectile dysfunction [5]. On a 1-to-10 satisfaction scale, approximately 72% of reviewers assigned a score of 8 or higher.

Those numbers come with a selection-bias warning. People who post drug reviews online tend to hold strong opinions. Satisfied users want to endorse. Dissatisfied users want to warn. The moderate middle, men who found tadalafil adequate but unremarkable, is underrepresented. This pattern is consistent across all patient-review platforms, not specific to tadalafil.

Reddit threads on r/erectile_dysfunction and r/Trt reflect the same split. A recurring theme in upvoted posts is surprise at the duration. One frequently cited user comment: "Took it Friday night, still working Sunday morning. Nothing else I tried did that." Conversely, a smaller but vocal subset reports headache severe enough to discourage repeat use. Back pain, which the FDA label lists at 6.5% incidence for the 20 mg dose, appears in forum complaints more often than clinical trial rates would predict, possibly because forums attract users seeking explanations for unexpected symptoms [3].

As-Needed vs. Daily Dosing: What Users Prefer and Why

Tadalafil is the only PDE5 inhibitor with an FDA-approved daily regimen (2.5 mg or 5 mg) in addition to the standard as-needed 10 mg or 20 mg doses [3]. That distinction shapes user experience reports in ways that clinical trial endpoints do not fully capture.

Daily-dosing users on forums emphasize spontaneity. Without needing to plan around a pill, sexual activity feels less medicalized. A 2007 crossover preference study by Stroberg et al. found that when men tried both daily tadalafil 5 mg and as-needed tadalafil 20 mg, 73% preferred the daily regimen, even though the as-needed dose produced slightly higher per-encounter IIEF scores [6]. The preference was driven almost entirely by the psychological benefit of not having to anticipate timing.

As-needed users, on the other hand, appreciate cost control. Generic tadalafil 20 mg tablets can be split (the tablet is scored), and men using the drug once or twice per week may find as-needed dosing cheaper than filling a 30-day daily prescription. Reddit threads frequently mention pill-splitting as a cost strategy, though the FDA label does not formally endorse it.

Men with concurrent benign prostatic hyperplasia (BPH) get a secondary benefit from daily dosing. The McVary et al. trial (N=1,058) demonstrated that tadalafil 5 mg daily reduced International Prostate Symptom Score (IPSS) by 4.9 points from baseline versus 2.3 for placebo at 12 weeks [7]. Several forum users with both ED and urinary symptoms describe daily tadalafil as a "two-for-one," managing erections and nocturia with the same prescription.

Head-to-Head Comparisons Users Make (and What Trials Support)

Forum discussions comparing tadalafil to sildenafil (Viagra) and vardenafil (Levitra) are among the most active threads in ED communities. Users frame the comparison around three axes: onset speed, duration, and side-effect profile.

Sildenafil and vardenafil both have half-lives near 4 hours, giving a practical activity window of roughly 4 to 6 hours. Tadalafil's 17.5-hour half-life extends that to 24 to 36 hours [3]. Forum users who switched from sildenafil to tadalafil overwhelmingly cite duration as the reason. "Viagra is a sprint. Cialis is a weekend," one user wrote in a post with over 200 upvotes.

On onset, sildenafil has a modest edge. Peak plasma concentration for sildenafil occurs at about 60 minutes versus 120 minutes for tadalafil on average [3][8]. Some users perceive tadalafil as "slower to kick in," though individual variability is wide. A high-fat meal delays sildenafil absorption significantly but has minimal effect on tadalafil, another practical advantage patients notice.

The 2011 Cialis prescribing information notes that tadalafil does not interact meaningfully with food or moderate alcohol intake [3]. Sildenafil's efficacy, by contrast, drops noticeably when taken after a fatty meal. For men who use ED medication in social settings involving dinner and drinks, this distinction matters. As Dr. Irwin Goldstein, editor of The Journal of Sexual Medicine, noted: "The clinical pharmacology of tadalafil was deliberately optimized to minimize lifestyle restrictions" [9].

Side-effect profiles differ subtly. Sildenafil causes more visual disturbance (blue-tinted vision) due to cross-reactivity with PDE6 in the retina. Tadalafil causes more back pain and myalgia, likely related to PDE11 inhibition in skeletal muscle [3]. Forum users rarely report vision changes with tadalafil but mention lower-back soreness with enough frequency to call it the drug's signature complaint.

Nonresponders: When Tadalafil Does Not Work

Roughly 20 to 35% of men in clinical trials did not achieve satisfactory erections on tadalafil, depending on the severity of baseline ED and comorbid conditions [1][2]. Forum discussions from nonresponders tend to follow a pattern: initial disappointment, dose escalation to 20 mg, and either a switch to another PDE5 inhibitor or a conversation with a prescriber about combination approaches.

Diabetes is the most common clinical predictor of reduced PDE5 inhibitor response. A subanalysis of the Brock et al. data showed that men with diabetes had lower IIEF improvement (approximately 5 points versus 7 points in the overall population), though the drug still outperformed placebo [1]. Men on antidepressants, particularly SSRIs, also report diminished response in both trials and forums.

The American Urological Association (AUA) guideline on erectile dysfunction states: "PDE5 inhibitor nonresponse should prompt evaluation of dosing adequacy, timing, sexual stimulation, and underlying vascular or neurogenic contributors before the agent is deemed ineffective" [10]. In practice, prescribers often find that dosing errors (taking tadalafil without allowing 60 minutes for onset, or expecting it to work without sexual arousal) account for a meaningful share of reported failures.

Some forum users describe partial response. They achieve erections but find rigidity insufficient. These reports align with the IIEF framework, which scores erectile function on a gradient rather than a binary pass/fail. A man whose IIEF domain score improves from 10 to 17 has made clinically significant progress but may still feel the result is inadequate for satisfying intercourse. Expectations set by marketing ("the weekend pill") can amplify that gap.

Safety Signals Users Should Know About

Tadalafil's cardiovascular safety profile has been studied extensively. The drug produces a mild systemic vasodilation, typically lowering systolic blood pressure by 1 to 2 mmHg in normotensive men [3]. That drop is clinically insignificant on its own but becomes dangerous when combined with nitrates (nitroglycerin, isosorbide mononitrate), which can produce severe hypotension. The combination is an absolute contraindication [3].

Alpha-blockers used for BPH (tamsulosin, doxazosin) can also interact. The FDA label recommends initiating tadalafil at 5 mg when co-prescribed with an alpha-blocker and monitoring for orthostatic symptoms [3]. Forum users occasionally report dizziness upon standing, particularly during the first week of combined therapy.

Priapism (erection lasting longer than 4 hours) is listed as a rare adverse event. The incidence in trials was less than 0.1%, and forum reports of true priapism with tadalafil are exceedingly uncommon [3]. Users sometimes confuse prolonged partial tumescence (a soft, persistent engorgement) with priapism, but the two conditions differ in clinical significance. Any erection lasting over 4 hours warrants emergency evaluation regardless.

Long-term safety data from open-label extension studies spanning up to 2 years showed no increase in adverse cardiovascular events, no hepatotoxicity signals, and stable tolerability [4]. The most persistent complaint in long-term users was mild headache, reported by about 15% of men at the start of therapy, declining to under 5% by month six as tolerance developed.

How Telehealth Changed Access and Feedback Volume

The availability of tadalafil through telehealth platforms increased sharply after generic entry in 2018 and accelerated again during 2020. Online prescribing services now account for a substantial share of new tadalafil prescriptions, and the feedback loop is tighter: patients order online, receive medication by mail, and post reviews on the same platform or on Reddit within days.

This shift has generated a large volume of user reports that did not exist a decade ago. The quality of those reports varies. Some are detailed, describing dose, timing, food intake, and response over multiple encounters. Others are single-sentence endorsements or complaints. Neither type replaces controlled trial data, but the volume provides a rough signal about real-world satisfaction that aligns with what the trials predicted.

One consistent finding across platforms: generic tadalafil manufactured by different companies produces variable user ratings. Some users report that specific generic manufacturers yield weaker effects. Whether this reflects true bioequivalence variation within FDA-allowed ranges (80 to 125% of reference AUC) or placebo-driven expectation bias is impossible to determine from forum data alone [11]. The FDA considers all approved generics therapeutically equivalent.

Putting User Reviews in Clinical Context

Forum data and clinical trials agree on the big picture. Tadalafil works for the majority of men with ED, its duration is genuinely longer than sildenafil or vardenafil, and back pain is its most distinctive side effect. Where they diverge is in emphasis. Trials measure IIEF domain scores and intercourse success rates. Users measure confidence, spontaneity, and relationship impact.

Both perspectives are valid. Neither is complete without the other. A man reading forum reviews should calibrate them against the trial data: expect roughly a 65 to 81% intercourse success rate on 10 to 20 mg, anticipate headache and possible back pain, allow 30 to 60 minutes for onset, and understand that tadalafil requires sexual arousal to work. The AUA recommends that initial PDE5 inhibitor selection be guided by patient preference, frequency of intercourse, and comorbidities rather than by efficacy differences between agents, which are modest [10].

Tadalafil 5 mg daily is the starting prescription for men who want continuous readiness or who also have BPH-related lower urinary tract symptoms. Tadalafil 10 mg as-needed is the labeled starting dose for episodic use, with escalation to 20 mg if response is insufficient [3].